Development of a risk score for intramyocardial hemorrhage in elderly STEMI patients after primary PCI: a retrospective cohort study with propensity score matching analysis - Top-Institutions - MDSpire

Development of a risk score for intramyocardial hemorrhage in elderly STEMI patients after primary PCI: a retrospective cohort study with propensity score matching analysis

  • By

  • Rui Wang

  • Cuijun Hao

  • Jiaqi Liu

  • Zhanshuai Zhang

  • Shaoqiang Qin

  • July 3, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    The First Affiliated Hospital of Hebei North University
    The First Affiliated Hospital of Hebei North University

    Shijiazhuang, Hebei

    Key Differentiators

    • Cardiology

  • #2

    University Medical Center Hamburg-Eppendorf
    University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

    Key Differentiators

    • Cardiology

  • #3

    University Hospital of Lyon
    University Hospital of Lyon

    Lyon, France

    Key Differentiators

    • Cardiology

  • #4

    Beijing Anzhen Hospital, Capital Medical University
    Beijing Anzhen Hospital, Capital Medical University

    Beijing, China

    Key Differentiators

    • Cardiology

  • #5

    Hezhou People's Hospital
    Hezhou People's Hospital

    Hezhou, Guangxi

    Key Differentiators

    • Cardiology

Original Source(s)

Development of a risk score for intramyocardial hemorrhage in elderly STEMI patients after primary PCI: a retrospective cohort study with propensity score matching analysis

  • by Rui Wang, Cuijun Hao, Jiaqi Liu, Zhanshuai Zhang, Shaoqiang Qin

  • July 3, 2026

Related Content

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets